Hui-Lin Pan Selected Research

Muscarinic Receptors (Muscarinic Acetylcholine Receptor)

11/2011	Diabetic neuropathy enhances voltage-activated Ca2+ channel activity and its control by M4 muscarinic receptors in primary sensory neurons.
12/2010	Dynamic control of glutamatergic synaptic input in the spinal cord by muscarinic receptor subtypes defined using knockout mice.
11/2003	Up-regulation of spinal muscarinic receptors and increased antinociceptive effect of intrathecal muscarine in diabetic rats.
9/2002	Role of presynaptic muscarinic and GABA(B) receptors in spinal glutamate release and cholinergic analgesia in rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hui-Lin Pan Research Topics

Disease

49	Neuralgia (Stump Neuralgia) 01/2023 - 02/2002
46	Pain (Aches) 01/2023 - 09/2002
28	Hypertension (High Blood Pressure) 04/2024 - 03/2006
28	Hypersensitivity (Allergy) 01/2023 - 06/2003
26	Hyperalgesia 01/2023 - 02/2002
12	Chronic Pain 01/2023 - 02/2002
9	Diabetic Neuropathies (Diabetic Neuropathy) 12/2022 - 11/2003
7	Inflammation (Inflammations) 12/2022 - 06/2003
6	Neoplasms (Cancer) 01/2023 - 03/2014
6	Peripheral Nervous System Diseases (PNS Diseases) 12/2022 - 01/2016
4	Ischemia 03/2022 - 02/2002
4	Postherpetic Neuralgia 01/2022 - 04/2005
3	Epilepsy (Aura) 01/2023 - 01/2010
3	Brain Ischemia (Cerebral Ischemia) 01/2023 - 10/2018
3	Brain Injuries (Brain Injury) 03/2022 - 10/2018
3	Peripheral Nerve Injuries 05/2019 - 09/2012
3	Painful Neuropathy 12/2017 - 08/2014
3	Myocardial Ischemia (Ischemic Heart Diseases) 07/2007 - 02/2002
2	Wounds and Injuries (Trauma) 01/2023 - 02/2015
2	Visceral Pain 01/2022 - 01/2022
2	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2022 - 01/2022
2	Nervous System Diseases (Neurological Disorders) 01/2021 - 01/2021
2	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 10/2020 - 10/2018
2	Infarction (Infarctions) 10/2018 - 07/2007
2	Myasthenia Gravis 12/2014 - 12/2009
2	Multiple Sclerosis 12/2014 - 12/2009
2	Spinal Cord Injuries (Spinal Cord Injury) 12/2014 - 12/2009
1	Colonic Neoplasms (Colon Cancer) 04/2024

Drug/Important Bio-Agent (IBA)

37	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2023 - 08/2009
28	Analgesics (Analgesic Drugs)IBA 01/2023 - 02/2002
13	Opioid Analgesics (Opioids)IBA 01/2023 - 12/2002
13	Glutamic Acid (Glutamate)FDA Link 01/2023 - 02/2002
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 12/2010
11	Gabapentin (Neurontin)FDA LinkGeneric 01/2023 - 04/2005
10	Morphine (MS Contin)FDA LinkGeneric 01/2023 - 06/2002
8	Calcineurin InhibitorsIBA 04/2024 - 04/2013
8	CannabinoidsIBA 01/2022 - 07/2009
8	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 01/2020 - 01/2005
7	Tacrolimus (Prograf)FDA LinkGeneric 04/2024 - 04/2013
7	Peptides (Polypeptides)IBA 01/2022 - 10/2018
6	Paclitaxel (Taxol)FDA LinkGeneric 01/2023 - 11/2014
6	CalcineurinIBA 12/2022 - 01/2012
6	Opioid Receptors (Opioid Receptor)IBA 10/2022 - 04/2016
5	N-Methylaspartate (NMDA)IBA 01/2022 - 08/2009
5	Memantine (Namenda)FDA Link 01/2022 - 08/2009
5	Streptozocin (Streptozotocin)FDA Link 11/2019 - 06/2002
5	Small Interfering RNA (siRNA)IBA 12/2018 - 02/2012
5	Casein Kinase II (Casein Kinase 2)IBA 10/2015 - 06/2011
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 04/2024 - 05/2014
4	resiniferatoxinIBA 01/2022 - 04/2003
4	AMPA Receptors (AMPA Receptor)IBA 01/2022 - 01/2012
4	Freund's AdjuvantIBA 02/2019 - 07/2009
4	Protein Kinase CIBA 01/2019 - 01/2016
4	CalpainIBA 10/2018 - 01/2012
4	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 11/2011 - 09/2002
3	Angiotensin IIIBA 12/2023 - 11/2018
3	Pregabalin (Lyrica)FDA Link 01/2023 - 01/2019
3	Calcium Channels (Calcium Channel)IBA 01/2023 - 05/2019
3	AnionsIBA 03/2022 - 01/2018
3	Messenger RNA (mRNA)IBA 01/2022 - 12/2010
3	CB2 Cannabinoid ReceptorIBA 01/2022 - 01/2016
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2017 - 09/2011
3	gamma-Aminobutyric Acid (GABA)IBA 01/2016 - 02/2007
3	ChloridesIBA 01/2016 - 06/2012
3	Cholinergic Agents (Cholinergics)IBA 11/2011 - 03/2003
3	BradykininIBA 07/2007 - 02/2002
2	Immunosuppressive Agents (Immunosuppressants)IBA 04/2024 - 12/2022
2	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2021
2	DNA (Deoxyribonucleic Acid)IBA 12/2023 - 01/2018
2	Corticotropin-Releasing HormoneIBA 01/2023 - 01/2023
2	CalciumIBA 01/2022 - 11/2019
2	Therapeutic UsesIBA 01/2022 - 01/2018
2	Ion Channels (Ion Channel)IBA 01/2022 - 09/2014
2	salicylhydroxamic acid (SHAM)IBA 01/2022 - 01/2022
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2021 - 01/2018
2	Protein Kinases (Protein Kinase)IBA 02/2019 - 09/2017
2	CytokinesIBA 02/2019 - 04/2013
2	iodoresiniferatoxinIBA 01/2019 - 09/2004
2	Netrin-1IBA 01/2019 - 10/2016
2	MuscarineIBA 12/2018 - 03/2003
2	InflammasomesIBA 01/2018 - 06/2015
2	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2018 - 11/2013
2	GhrelinIBA 04/2017 - 01/2017
2	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2016 - 09/2012
2	4-Aminopyridine (4 Aminopyridine)FDA Link 12/2014 - 12/2009
2	metabotropic glutamate receptor type 1IBA 03/2014 - 01/2010
2	Glycine Receptors (Glycine Receptor)IBA 02/2014 - 06/2012
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2012 - 09/2010
2	GABA-B ReceptorsIBA 08/2008 - 03/2003
2	Capsaicin (Zostrix)FDA Link 04/2005 - 04/2003
2	AcidsIBA 01/2005 - 02/2002
2	Neostigmine (Neostigmine Bromide)IBA 11/2003 - 03/2003
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2003 - 09/2002
2	D-Penicillamine (2,5)- EnkephalinIBA 01/2003 - 12/2002
1	SulfurIBA 04/2024

Therapy/Procedure

20	Spinal Injections 01/2023 - 11/2003
7	Drug Therapy (Chemotherapy) 01/2023 - 11/2014
7	Electroacupuncture 01/2022 - 07/2009
5	Ligation 01/2023 - 02/2002
3	Analgesia 12/2022 - 01/2019